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Progesterone, or rather its neuroactive metabolite allopregnanolone, modulates amygdala activity and thereby influences anxiety. Cog-
nition and, in particular, memory are also altered by allopregnanolone. In the present study, we investigated whether allopregnanolone
modulates memory for biologically salient stimuli by influencing amygdala activity, which in turn may affect neural processes in other
brain regions. A single progesterone dose was administered orally to healthy young women in a double-blind, placebo-controlled,
crossover design, and participants were asked to memorize and recognize faces while undergoing functional magnetic resonance imag-
ing. Progesterone decreased recognition accuracy without affecting reaction times. The imaging results show that the amygdala, hip-
pocampus, and fusiform gyrus supported memory formation. Importantly, progesterone decreased responses to faces in the amygdala
and fusiformgyrusduringmemoryencoding,whereas it increasedhippocampal responses.Theprogesterone-induceddecrease inneural
activity in the amygdala and fusiform gyrus predicted the decrease inmemory performance across subjects. However, progesterone did
not modulate the differential activation between subsequently remembered and subsequently forgotten faces in these areas. A similar
pattern of results was observed in the fusiform gyrus and prefrontal cortex duringmemory retrieval. These results suggest that allopreg-
nanolone impairs memory by reducing the recruitment of those brain regions that support memory formation and retrieval. Given the
important role of the amygdala in themodulation of memory, these results suggest that allopregnanolone alters memory by influencing
amygdala activity, which in turn may affect memory processes in other brain regions.
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Introduction
Changes in gonadal steroid hormone levels are associated with
changes in mood regulation (Steiner et al., 2003) and cognition
(Kimura, 1999). For example, the highest physiological levels of
progesterone and estradiol are reached during pregnancy, which
is accompanied by a worsening of mood and a decrease in mem-
ory performance (Sharp et al., 1993; Keenan et al., 1998; Buck-
walter et al., 1999; de Groot et al., 2003; Bennett et al., 2004). The
more modest hormone level changes during the menstrual cycle
have more subtle and variable effects on mood and cognition in
healthy women (Hampson, 1990; Phillips and Sherwin, 1992;
Sveindottir and Backstrom, 2000; Maki et al., 2002) but induce
negative mood symptoms and impair memory in women with
premenstrual syndrome (Schmidt et al., 1998; Schmitt et al.,
2005). These effects are potentially mediated by the neuroactive
metabolites of progesterone. The metabolite allopregnanolone
potentiates the inhibitory effect of GABA by modulating the
GABAA receptor (Majewska et al., 1986) and has been suggested
to mediate the negative effects of progesterone on mood (N-
Wihlba¨ck et al., 2006) and memory (Brett and Baxendale, 2001).
Although allopregnanolone can also induce paradoxical effects at
moderate concentrations (Fish et al., 2001; Andre´en et al., 2006;
van Wingen et al., 2007), animal studies suggest that allopreg-
nanolone usually decreases anxiety (Bitran et al., 1991, 1995;
Wieland et al., 1991) and impairs memory (Ladurelle et al., 2000;
Johansson et al., 2002), suggesting a possible relationship be-
tween the effects of allopregnanolone on emotion and memory.
Allopregnanolone induces its anxiolytic effect by action on the
amygdala (Akwa et al., 1999), a brain structure that is known to
influence various cognitive processes during emotional experi-
ences, including memory formation (Cahill et al., 1996; Canli et
al., 2000). Animal studies have shown that the amygdalamediates
the mnemonic effects of GABAergic drugs (Brioni et al., 1989).
Specifically, the basolateral amygdala appears critical in mediat-
ing the amnesic effects of benzodiazepines (Tomaz et al., 1992).
Hence, a modulation of basolateral amygdala activity by proges-
terone and/or allopregnanolone, with putative indirect effects on
other brain regions such as the hippocampus (Richardson et al.,
2004) or the inferior temporal cortex (ITC), might link hormone
action with memory performance.
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To test this hypothesis, we combined a single progesterone
administration to healthy young women with functional mag-
netic resonance imaging (fMRI) in a double-blind, placebo-
controlled, crossover design. During scanning, participants were
asked to memorize and recognize faces. The perception of faces
elicits amygdala activity (Somerville et al., 2004; Fitzgerald et al.,
2006), and the amygdala modulates the neural response to faces
in the fusiform gyrus (Vuilleumier et al., 2004). This brain region
is preferentially involved in face processing (Kanwisher et al.,
1997) and presumably involved in face memory storage (Mi-
yashita, 1993). Whereas the amygdala modulates memory con-
solidation in other brain regions (McGaugh, 2004), the prefron-
tal cortex exerts executive control during memory retrieval of
visual representations in the ITC (Tomita et al., 1999). Therefore,
we hypothesized that allopregnanolone impairsmemory for faces
by modulating ITC activity, potentially by modulating amygdala
activity during encoding and prefrontal activity during retrieval.
By adopting a factorial event-related fMRI design, we are able
to identify themechanism bywhich allopregnanolonemodulates
memory formation and retrieval. Initially, we identified brain
regions supportingmemory by comparing neural responses dur-
ing study and test to items remembered or forgotten on the (sub-
sequent) memory test (i.e., main effect of memory). If allopreg-
nanolone impairs memory performance by altering these neural
processes, it would change the differential activation between
(subsequent) hits and (subsequent) misses, as reflected by a sig-
nificant drug  memory interaction. Conversely, allopreg-
nanolone may not change these memory processes per se, but it
may impair memory performance by altering the recruitment of
these neural processes (cf. Uncapher and Rugg, 2005). Allopreg-
nanolone would then reduce the response amplitudes to both
(subsequent) hits and (subsequent) misses within those brain
regions that support memory, as reflected by a significant con-
junction between the main effects of drug and memory.
Materials andMethods
Participants. Eighteenwomenwith amean age of 24 years (range, 19–39)
gave written informed consent to participate in this study, which had
been approved by the local medical ethics committee (CMO Regio
Arnhem-Nijmegen, The Netherlands). The participants were healthy as
determined by routine physical and laboratory examinations, had no
current neurological or psychiatric disorder as measured by a structured
interview [MINI (Mini-International Neuropsychiatric Interview)]
(Sheehan et al., 1998), and reported no history of psychiatric or somatic
disease potentially affecting the brain. They were right handed, free of
medication, did not use hormonal contraceptives, and had a regular
menstrual cycle. Data of one subject were lost because of a technical
failure, and data of another were excluded because of chance-level rec-
ognition performance. Therefore, the results are based on the data of 16
participants.
Study design and procedure. Subjects participated twice during the
early follicular phase (days 2–7) of different menstrual cycles to ensure
low endogenous gonadal steroid hormone levels. The estimated median
duration between sessions was 2.1 (interquartile range, 1.9) menstrual
cycles. They arrived at 8:15 A.M. after an overnight fast to receive a
standardized light breakfast, after which 400 mg of micronized proges-
terone or placebo was administered, in a double-blind, crossover man-
ner. The progesterone dose was administered orally, to increase the allo-
pregnanolone concentration to a similar extent (de Lignieres et al., 1995).
Administration was randomized among pairs of subjects, to ensure that
the order of versions of the memory paradigm was the same per subject-
pair (see below). A venous blood sample was collected before drug ad-
ministration, before scanning, and after scanning (0, 80, and 190 min
relative to the drug administration). In addition, subjects completed the
mood rating scale (MRS) (Bond and Lader, 1974) before scanning and
the state version of the state trait anxiety inventory (STAI) (Spielberger et
al., 1970) after scanning. The MRS contains 16 visual analog scales that
measure the three principal components alertness (scoring range,
0–625.2), contentedness (0–352.9), and calmness (0–152.2). The STAI
is a 20-item, four-point Likert scale that measures state anxiety (20–80).
Serum analysis. Progesterone was measured with Delfia progesterone
kits (Wallac, Turku, Finland) according to the manufacturer’s instruc-
tions. Allopregnanolone was measured with a radioimmunoassay after
diethylether extraction andCelite chromatography (recovery, 78%). The
antiserumwas raised against 3-hydroxy-20-oxo-5-pregnan-11-yl car-
boxymethyl ether-BSA (a gift fromDr. R. H. Purdy, College ofMedicine,
University of California San Diego, La Jolla, CA) with low cross-
reactivity. The intra-assay coefficient of variation was 6.5%, and the
inter-assay coefficient of variation was 8.5% (Andre´en et al., 2005).
Memory paradigm. The subjects completed four study–test cycles dur-
ing scanning. During study, subjects had to memorize pictures of male
and female faces, while making a gender decision. During test, they had
to recognize these pictures among a series of new pictures and tomake an
old, new, or unsure decision. For three subjects, only two study–test
cycles were available for one session, in which case only the respective
cycles from the other session were used.
The stimuli consisted of faceswith a neutral tomildly happy emotional
expression and with direct gaze direction. They were derived from dif-
ferent stimulus sets (Ekman and Friesen, 1976) [the Karolinska Directed
Emotional Faces (1998; D. Lundqvist, A. Flykt, and A. O¨hman, Karolin-
ska Institute, Stockholm, Sweden) and the AR face database (1998; A.
Martinez and R. Benavente, Purdue University,West Lafayette, IN)] and
the internet. All photos were edited (Photoshop 6.0; Adobe Systems, San
Jose, CA) to produce oval grayscale pictures that showed the face from
chin to forehead and excluded the ears. The 960 stimuli were divided over
eight blocks of 120 faces each, which did not differ in the amount of
features (50%male, 24% glasses, 6% facial hair, and 4% non-Caucasian;
 2(21) 1.5, NS). Half of the stimuli per block were used as study items,
and half were used as distractors during test. In addition, half of the
blocks were used per session. These two factors were counterbalanced
over subject-pairs. The stimuli were pseudo-randomly intermixed with
10 null events (2 s) per study and per test phase, such that there were no
more than four consecutive presentations per gender or old/new status of
the stimulus. All faces were presented for 0.8 s with an interstimulus
interval of 3.3–4.3 s. The discrimination index d was used as a measure
of recognition accuracy, which was calculated as the z score of the hit rate
minus the z score of the false-alarm rate (Hochhaus, 1972). The hit and
false-alarm rates were defined as the number of hits or false alarms di-
vided by the number of old or new trials for which an old or new decision
was made.
Image acquisition.MRdata were acquired with a 1.5T Siemens (Erlan-
gen, Germany) Sonata MR scanner, equipped with a standard head coil.
Two runs of 854 T2*-weighted blood oxygenation level-dependent
(BOLD) images were acquired using echo-planar imaging (EPI) with
each image volume consisting of 33 axial slices [3 mm, 0.5 mm slice gap;
repetition time (TR), 2.290 s; echo time (TE), 30ms; 64 64matrix; field
of view (FOV), 224 mm; flip angle, 90°]. In addition, a high-resolution
T1-weighted structuralMR imagewas acquired for spatial normalization
procedures [3D MP-RAGE (magnetization-prepared rapid gradient-
echo); TR, 2250 ms; TE, 3.93 ms; 176 contiguous 1 mm slices; 256 256
matrix; FOV, 256 mm].
Image analysis. Image analysis was performed with SPM2 (Wellcome
Department of Imaging Neuroscience, London, UK). The first five EPI
volumes were discarded to allow for T1 equilibration, and the remaining
images were realigned to the first volume. Images were then corrected for
differences in slice acquisition time, spatially normalized to theMontreal
Neurological Institute (MNI) T1 template, super-sampled into 2 2 2
mm3 voxels, and spatially smoothed with a Gaussian kernel of 10 mm
full-width at half-maximum.
Statistical analysis was performed within the framework of the general
linear model (Friston et al., 1995). Later remembered and later forgotten
stimuli were separately modeled for the study phase, as were hits, misses,
correct rejections, and false alarms for the test phase. Stimuli with an
incorrect gender decision or omission during study, or with an unsure
van Wingen et al. • How Progesterone Impairs Memory J. Neurosci., October 17, 2007 • 27(42):11416–11423 • 11417
response or omission during test, were included in a condition of no
interest. The explanatory variables (0.8 s) and null events (2 s) were
temporally convolved with the canonical hemodynamic response func-
tion of SPM2. In addition, the realignment parameters were included to
model potential movement artifacts as well as a high-pass filter (cutoff at
1/128 Hz). To account for various global effects, the EPI data were pro-
portionally scaled. Temporal autocorrelation was modeled with an
AR(1) process, and the parameter estimates were obtained by maximum
likelihood estimation (Friston et al., 2002) to allow for departures from
sphericity. The relevant parameter images contrasting each condition to
null events were entered in a random-effects repeated-measures ANOVA
with a nonsphericity correction. Statistical tests were family-wise error
rate corrected for multiple comparisons across the entire brain. A small
volume correction was used to correct for multiple comparisons across
the search volume for regions of interest (Worsley et al., 1996). Because
the basolateral amygdala mediates the amnesic effects of diazepam
(Tomaz et al., 1992), the search volume for the amygdala was defined as
a sphere with 7 mm radius around the probabilistic cytoarchitectonic
center of the basolateral amygdala [(26,8,18) and (28,8,18)],
which approximates total amygdala volume (Amunts et al., 2005; Eick-
hoff et al., 2005). Correspondingly, the hippocampal search volume was
defined as a sphere with 10 mm radius around the center of the Cornu
ammonis [(28, 28, 8) and (28, 26, 8)]. In addition, the face-
responsive region in the fusiform gyrus was defined as a sphere with 10
mm radius around previously reported Talairach coordinates (Kan-
wisher et al., 1997), which were transformed into MNI space [http://
imaging.mrc-cbu.cam.ac.uk/imaging/MniTalairach; (36, 64, 16)
and (40,56,16)]. To exclude a general effect of the drug administra-
tion on the BOLD response, the primary visual cortex (V1) was used as
the control region, which was defined analogously to the hippocampus
(Amunts et al., 2000). The maxima of significant clusters are reported in
MNI coordinates.
Hypothesis testing. Statistical tests were performed separately for en-
coding and retrieval. The main effects of drug and memory and the
drug  memory interaction were estimated by contrasting the relevant
task conditions. The main effects of memory were investigated by com-
paring neural responses for subsequent hits and subsequent misses dur-
ing encoding and for hits and misses during retrieval, collapsed across
drug conditions. The main effects of drug were investigated by compar-
ing the responses for all trials versus null events between drug conditions.
In addition, conjunction analyses were performed that tested the global
null hypothesis using the minimum T statistic as implemented within
SPM2, to confirm the regional overlap between themain effects of mem-
ory and drug (Friston et al., 2005). To assess the relationship between
neural activity and memory performance across subjects, mean activity
within each significant conjunction cluster ( p 0.001, uncorrected) was
extracted (Brett et al., 2002), and the differences in activity between the
progesterone and placebo conditions were entered in regression analyses
through the origin as a predictor for the difference in memory
performance.
Results
Serum concentrations and questionnaires
The progesterone administration increased both the serum pro-
gesterone and allopregnanolone concentrations (condition 
time interaction; progesterone: F(2,12)  5.8, p  0.05; allopreg-
anolone: F(2,12)  23.9, p  0.001) (Table 1). As expected, the
baseline concentrations were not significantly different between
the progesterone and placebo sessions (progesterone: t(15) 0.6,
p 0.5; allopregnanolone: t(15) 1.6, p 0.1). The progesterone
administration produced serum concentrations of allopreg-
nanolone that are similar to those reached during pregnancy
(Luisi et al., 2000). However, progesterone had no significant
effects on alertness [progesterone (mean SEM), 410.1 19.3;
placebo, 417.2 12.9; t(15) 0.3; p 0.7], contentedness (pro-
gesterone, 271.4 8.7; placebo, 273.7 7.2; t(15) 0.4; p 0.7),
and calmness (progesterone, 108.9  5.3; placebo, 115.2  3.6;
t(15) 1.5; p 0.1) as measured with the MRS before scanning,
nor on state anxiety (STAI; progesterone, 32.6  1.5; placebo,
33.8  1.0; t(15)  0.7; p  0.4) after the scanning session, al-
though the allopregnanolone concentration after scanningwas in
the range that could induce sedation (Timby et al., 2006). Differ-
ences in behavioral performance and neural activations can
therefore not be explained by effects of progesterone on anxiety
or mood states.
Progesterone decreases memory performance
The participants were asked to make a gender decision during
the study phase of the memory task. Progesterone did not
significantly affect the decision accuracy or reaction times [ac-
curacy and reaction times (mean  SEM); progesterone:
93.8 0.8%, 1051 61 ms; placebo: 94.3 1.2%, 1102 68
ms; both p  0.3), again indicating that progesterone was not
sedative.
Critically, progesterone decreased the recognition accuracy
for faces during the test phase of the memory task (d; proges-
terone, 0.75  0.06; placebo, 0.87  0.09; t(15)  2.2; p 
0.05). The hit and false-alarm rates during the progesterone
condition were 66.1  3.1 and 38.3  2.8%, respectively, and
68.6  2.2 and 36.4  3.6% during the placebo condition.
Reaction times during the test phase were fastest for hits and
slowest for misses (hits  false alarms  correct rejections 
misses; F(3,13)  8.9; p  0.005; all paired t tests, p  0.005),
but the reaction times were not significantly affected by pro-
gesterone (hits, false alarms, correct rejections, misses; pro-
gesterone: 1319  36, 1396  42, 1509  54, and 1588  72
ms; placebo: 1362 51, 1457 56, 1531 60, and 1624 72
ms; all F  1). In summary, the behavioral results show that
progesterone specifically decreased recognitionmemory accu-
racy, without affecting other behavioral measures.
Neural mechanism of the progesterone induced
memory impairment
Memory encoding
To investigate whether progesterone decreased recognition
memory accuracy for faces already by modulating neural activity
during encoding, brain regions that supported the successful en-
coding of faces were identified first. This main effect of memory
was investigated by comparing encoding activity of subsequent
hits and subsequent misses and showed that the amygdala, the
hippocampus, and the fusiform gyrus supportedmemory forma-
tion of faces. In addition, regions in the bilateral inferior tempo-
ral gyri (extending to the fusiform gyri) and left middle occipital
gyrus showed a larger response to subsequent hits than subse-
quent misses (Table 2).
Second, the main effect of drug administration showed that
progesterone decreased the response of the amygdala and the
fusiform gyrus while viewing the faces (i.e., faces vs null events).
In contrast, progesterone increased the response in the hip-
pocampus (Table 2). However, the progesterone administration
did not significantly modulate the response in the primary visual
Table 1. Serum concentrations of progesterone and allopregnanolone after the
oral administration of 400mg ofmicronized progesterone (nmol/L)
Time (min) Progesterone Allopregnanolone
0 (baseline) 1.9 0.3 0.6 0.1
80 (before fMRI session) 16.2 7.3 23.3 8.4
190 (after fMRI session) 174.2 68.4 185.8 26.6
Data are mean SEM.
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cortex, indicating that the drug effects in the other brain regions
were not attributable to general changes in the BOLD response.
Third, a conjunction analysis was performed to confirm the
spatial overlap of the main effect of memory and the main effect
of drug. This analysis showed that the amygdala [(24,12,22);
T2(45)  2.3; p  0.007, corrected] (Fig. 1A,B), the fusiform
gyrus [left (38, 70, 12), T2(45)  2.4, p  0.01, corrected;
right (40, 52, 16), T2(45)  3.3, p  0.036, whole-brain cor-
rected] (Fig. 1D,E), and the middle temporal gyrus [(56, 40,
12), T2(45) 3.7, p 0.002, whole-brain corrected] supported
memory formation and that progesterone decreased the response
of these brain regions.
Fourth, to assess whether the progesterone-induced decrease
in activity is related to the decrease in memory performance
across subjects, the difference in activity between the progester-
one and placebo sessions was entered in a regression analysis as
predictor for the difference in memory performance. The de-
crease in right amygdala (R2  0.36; p 
0.005, one-tailed) (Fig. 1C) and right fusi-
form gyrus (R2  0.30; p  0.012, one-
tailed) (Fig. 1F) activity was positively re-
lated to thedecrease indacross subjects (i.e.,
the extent to which progesteronemodulates
activity within these brain regions predicted
the effect of progesterone on memory
performance).
Importantly, the results showed no sig-
nificant drugmemory interaction. This
suggests that progesterone did not modu-
late memory formation per se, because
progesterone did not change the differen-
tial response between subsequent hits and
subsequent misses.
Recognition memory
To investigate whether progesterone de-
creased recognition memory accuracy
also by modulating neural activity dur-
ing retrieval, brain regions that sup-
ported the successful recognition of
faces were identified first. The main ef-
fect of memory was investigated by com-
paring the recognition activity of hits
and misses and showed that the fusiform
gyrus also supported the recognition of
faces. In addition, regions in the caudate
nuclei, bilateral inferior frontal gyri, and
middle cingulate gyrus showed a larger
response to hits than misses (Table 3).
Second, as during encoding, the main
effect of drug administration during rec-
ognition showed that progesterone de-
creased fusiform gyrus responses while
subjects viewed faces (i.e., all faces vs null
events). It also decreased the response in
the left inferior frontal gyrus (Table 3) but
did not significantly modulate the re-
sponse in the primary visual cortex.
Third, the conjunction analysis showed
that the fusiform gyrus [left (32, 64,
16), T2(45)  2.4, p  0.01, corrected;
right (46, 56, 10), T2(45)  3.7, p 
0.005, whole-brain corrected] (Fig. 2A,B)
and the inferior frontal gyrus ( p 0.001,
uncorrected; cluster, 20 voxels) (Fig. 2D,E) supported recog-
nition memory and that progesterone decreased the response of
these brain regions.
Fourth, the regression analyses with the difference in activity
between the progesterone and placebo sessions as predictor for
the difference in memory performance across subjects showed
that the decrease in right fusiform gyrus (R2  0.41; p  0.003,
one-tailed) (Fig. 2C) and left inferior frontal gyrus (R2  0.19;
p  0.04, one-tailed) (Fig. 2F) activity was positively related to
the decrease in d across subjects. As during encoding, the extent
to which progesterone modulated activity within these brain re-
gions during recognition also predicted the effect of progesterone
on memory performance.
Again, the drugmemory interaction showed no significant
modulation of recognition processes, which suggests that proges-
terone did not modulate memory retrieval per se.
Table 2. Cluster maxima for brain regions showing amain effect of successful memory encoding for faces (i.e.,
subsequent hits> subsequentmisses) or amain effect of drug administration (i.e., progesterone vs placebo) on
the response to all faces (i.e., faces vs null events)
MNI coordinates
Cluster size t pax y z
Subsequent hits subsequent misses
R fusiform gyrus 48 52 16 109 5.2 0.001
L fusiform gyrus 42 68 10 30 3.7 0.017
R amygdala 24 4 22 19 3.5 0.013
L amygdala 24 6 12 4 3.0 0.042
L hippocampus 24 34 2 5 3.5 0.026
L middle occipital gyrus 34 88 20 62 4.1 0.001b
Placebo progesterone
R fusiform gyrus 36 54 14 91 4.1 0.006
L amygdala 32 8 18 6 3.0 0.038
Progesterone placebo
R hippocampus 22 28 4 23 4.0 0.009
MNI coordinates of cluster maximum are shown; the cluster size is in number of significant voxels. R, Right; L, left.
aThe p values are corrected for multiple comparisons across the search volume ( p 0.05).
bThe p value is uncorrected for multiple comparisons ( p 0.001; k 20).
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Figure 1. Progesterone reduced the recruitment of the amygdala and fusiform gyrus, brain regions that supported memory
formation of faces, during memory encoding. A, Significant conjunction of main effect of memory (i.e., subsequent hits 
subsequentmisses) andmain effect of drug [i.e., placebo (facesnull events)progesterone (facesnull events)] in the right
amygdala ( y12;p0.001, uncorrected).B, Parameter estimates of the conjunction cluster (arbitraryunits;meanSEM).
C, The progesterone-induced decrease in amygdala activity predicted the decrease in memory performance across subjects
[recognition memory accuracy (d)]. D–F, Identical figures for the significant conjunction of main effects in the right fusiform
gyrus ( y52). SH, Subsequent hits; SM, subsequent misses; a.u., arbitrary units.
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Discussion
The results of the present study demonstrate that a single proges-
terone administration impairs memory for faces by reducing the
neural response in the amygdala and fusiform gyrus during
memory encoding and in the fusiform gyrus and prefrontal cor-
tex during memory retrieval. Moreover, the progesterone-
induced decrease in activation predicted the decrease in memory
performance across subjects. However, progesterone did not af-
fect the memory processes per se, because progesterone did not
change the differential activity between (subsequent) hits and
(subsequent)misses. Therefore, these results suggest that proges-
terone impairs memory by reducing the recruitment of those
brain regions that support memory. Hence, our data reveal a
neural mechanism by which progesterone affects memory for
biologically salient stimuli, which links the influence of proges-
terone on emotion and memory. This mechanism may contrib-
ute to changes in mood regulation and cognition that are ob-
served during the menstrual cycle and pregnancy.
Animal studies suggest that the acute effects of progesterone
on memory are mediated by its neuroactive metabolite allopreg-
nanolone, which potentiates the inhibitory actions of GABA
(Majewska et al., 1986). Direct allopregnanolone administrations
to rodents impair memory performance (Ladurelle et al., 2000;
Johansson et al., 2002), and this learning impairment can be
blocked by an allopregnanolone antagonist on the GABAA recep-
tor (Turkmen et al., 2004). Also, human studies suggest that the
progesterone-induced impairment of verbal recall is related to
allopregnanolone levels (Freeman et al., 1992, 1993). However,
memory effects in those studies are potentially mediated by the
sedative effects of allopregnanolone, because the progesterone
administrations also increased fatigue. Our results show that the
effects of progesterone and/or allopregnanolone on memory are
not merely a consequence of its sedative effects, because proges-
terone did not affect subjective (questionnaires) or objective (re-
action times) measures of alertness.
The results of the present study suggest that progesterone im-
pairs memory by reducing the recruitment of those neural pro-
cesses that support memory, without affecting those processes
directly. This pattern of results likely reflects the specific
GABAergic action of allopregnanolone and thereby the GABAer-
gic modulation of memory formation and retrieval. Glutamate
but not GABA turnover is crucial for memory by inducing long-
term potentiation (LTP) via NMDA receptor activation (Morris
et al., 1986). Indeed, NMDA receptor antagonists impair human
memory by affecting medial temporal lobe memory processes
(Grunwald et al., 1999). In contrast, allopregnanolone reduced
the response amplitude to all stimuli, regardless of whether the
item was memorized or retrieved successfully. Because the acti-
vation in BOLD fMRI mainly reflects excitatory neurotransmis-
sion (Waldvogel et al., 2000), these results suggest that allopreg-
nanolone impairs memory via a GABAergic mechanism by
increasing the threshold of excitatory neurons to initiate LTP.
This is likelymediated by themodulation of allopregnanolone on
extrasynaptic -subunit containing GABAA receptors, which en-
hances tonic inhibition and thereby decreases neuronal excitabil-
ity (Stell et al., 2003). By increasing the threshold, allopreg-
nanolone would reduce the probability that LTP is initiated. This
suggests that allopregnanolone impairs memory by reducing the
probability of successful memory encoding.
A similar spatial overlap of two main effects without an inter-
action have been observed for memory formation and divided
attention (Uncapher and Rugg, 2005). Divided attention also
impairs memory by reducing the probability of engaging encod-
ing processes that support later episodic retrieval. However, di-
vided attention also decreased the encoding efficiency in that
study, because it decreased the encoding accuracy and increased
reaction times. This is clearly different from the memory-
impairing effects of progesterone, because our results show no
evidence of decreases in processing efficiency. It is therefore un-
likely that our results reflect a progesterone-inducedmodulation
of attention. This discrepancy with the effect of divided attention
suggests that our results rather reflect a specific effect of proges-
terone on brain regions identified here as relevant for memory
formation and retrieval.
The results suggest that progesterone impairs memory for
faces by decreasing amygdala activity during memory encoding,
because the amygdala supported memory formation in this
study. The amygdala is essentially involved in the enhancement of
memory for various emotional stimuli (Cahill et al., 1995; Rich-
ardson et al., 2004; Strange andDolan, 2004), which suggests that
the amygdala may also mediate the effect of progesterone on
memory for other emotional stimuli. The memory enhancement
for emotional stimuli is determined by the degree of amygdala
activity and arousal during encoding (Cahill et al., 1996; Canli et
al., 2000). The progesterone-induced decrease in amygdala re-
sponse as observed here might thus be associated with the anxi-
olytic effects of allopregnanolone (Bitran et al., 1995; Akwa et al.,
1999). These results therefore suggest that progesterone may im-
pair memory by decreasing arousal.
Progesterone also decreased the neural response in the fusi-
form gyrus. This brain region is preferentially involved in the
processing of faces (Kanwisher et al., 1997; Tsao et al., 2006), and
face memory traces are potentially stored in this brain region
(Miyashita, 1993; Ishai et al., 2000). These results therefore sug-
gest that progesterone impairs memory for faces by reducing the
neural response in the fusiform gyrus, which is a potential con-
sequence of the modulation of progesterone of amygdala activity
during memory encoding. The amygdala influences emotional
memory by modulating memory consolidation in other brain
regions (Packard et al., 1994; Kilpatrick and Cahill, 2003; Mc-
Gaugh, 2004; Richardson et al., 2004) and projects back to all
levels of the ventral visual stream (Amaral et al., 2003). Impor-
tantly, it modulates activity in the fusiform gyrus during face
perception (Vuilleumier et al., 2004). Therefore, the progester-
one induced decrease in fusiform gyrus activitymay result from a
decrease inmodulatory influences from the amygdala. This study
Table 3. Cluster maxima for brain regions showing amain effect of successful
memory retrieval of faces (i.e., hits>misses) or amain effect of drug
administration (i.e., progesterone vs placebo) on the response to all faces (i.e.,
faces vs null events)
MNI coordinates
Cluster size t pax y z
Hitsmisses
R fusiform gyrus 46 56 10 44 4.0 0.008
R/L caudate nuclei 14 2 16 479 4.7 0.001b
R inferior frontal gyrus 40 40 12 63 4.3 0.001b
L inferior frontal gyrus 44 30 16 37 3.7 0.001b
Middle cingulate cortex 4 2 34 55 3.7 0.001b
Placebo progesterone
R fusiform gyrus 42 58 12 330 5.1 0.001
L fusiform gyrus 34 66 12 21 3.5 0.030
L inferior frontal gyrus 56 14 14 37 3.7 0.001b
MNI coordinates of cluster maximum are shown; the cluster size is in number of significant voxels. R, Right; L, left.
aThe p values are corrected for multiple comparisons across the search volume ( p 0.05).
bThe p values are uncorrected for multiple comparisons ( p 0.001; k 20).
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cannot clarify whether progesterone has an indirect effect via the
amygdala or a direct effect on the fusiform gyrus, but progester-
one reduced functional coupling of the amygdala with the fusi-
form gyrus in a blocked design with faces as stimuli (vanWingen
et al., 2007). Those results suggest that themodulation of proges-
terone of amygdala activity influences fusiform gyrus activity, but
the correlational analysis used precluded a directional interpre-
tation. However, animal studies using amygdala lesion and drug
infusion methods suggest that benzodiazepines induce their am-
nesic effects by decreasing (basolateral) amygdala activity (Brioni
et al., 1989; Tomaz et al., 1992), likely by decreasing norepineph-
rine turnover within the amygdala (Hatfield et al., 1999). We
therefore suggest that progesterone impairs memory by its con-
version to allopregnanolone, thereby decreasing amygdala activ-
ity and its modulatory influence, which in turn downregulates
memory encoding and consolidation in the fusiform gyrus.
The reduced neural responses in the inferior frontal gyrus
could also contribute to the reduced fusiform gyrus responses
during memory retrieval. The prefrontal cortex exerts executive
control during the active retrieval of memory representations in
the ITC (Tomita et al., 1999; Miyashita, 2004). The reduced pre-
frontal activity may therefore reflect a progesterone-induced re-
duction in strategic retrieval attempts. The reduction in active
top-down signaling from the prefrontal cortexmay subsequently
reduce neural activity in the fusiform gyrus because of a reduc-
tion in search attempts.
Other human imaging studies suggest that interactions be-
tween the amygdala and the anterior hippocampus are crucial for
emotional memory formation (Dolcos et al., 2004; Richardson et
al., 2004). However, the results of the present study show that
progesterone even increased posterior hippocampal activity
while memory performance decreased. This discrepancy may be
explained by the dissociation within the medial temporal lobe,
because the anterior but not posterior medial temporal lobe sup-
ports emotional memory formation (Dolcos et al., 2004). The
progesterone-induced hippocampal activity increase may reflect
the recruitment of a compensatory neural mechanism in an at-
tempt to maintain adequate memory perfor-
mance (Voermans et al., 2004).
Previous studies have shown that proges-
terone and the hormonal changes during the
menstrual cycle influence amygdala activity
(Goldstein et al., 2005; Dreher et al., 2007;
vanWingen et al., 2007). Whereas progester-
one decreased amygdala responses in the
present study, progesterone can also increase
amygdala activity (van Wingen et al., 2007).
Although this apparent discrepancy could be
attributable to differences in the experimen-
tal paradigms used, recent studies suggest
that it is more likely explained by differences
in allopregnanolone concentration. Whereas
allopregnanolone usually decreases anxiety
in animal studies (Bitran et al., 1991;Wieland
et al., 1991),moderate concentrations can in-
crease aggressive behavior (Fish et al., 2001).
Moreover, women who reach moderate allo-
pregnanolone concentrations during hor-
monal replacement therapy develop negative
mood symptoms more often than women
reaching lower and higher concentrations
(Andre´en et al., 2006). The paradoxical
amygdala activity increase in a previous study
was observed after progesterone levels had increased from the
follicular to the luteal phase range (van Wingen et al., 2007),
whereas progesterone levels increased to levels that are reached
during pregnancy in the present study (Luisi et al., 2000). This
suggests that allopregnanolone may modulate amygdala activity
in a nonlinear dose-dependent manner, increasing amygdala ac-
tivity at moderate concentrations, while decreasing amygdala ac-
tivity at higher concentrations.
The modulation of allopregnanolone on amygdala activity
may influence anxiety. Indeed, animal studies have shown that
intra-amygdala infusions of allopregnanolone decreases anxiety
(Akwa et al., 1999). Furthermore, inhibiting the metabolization
of progesterone to allopregnanolone within the amygdala in-
creases anxiety (Walf et al., 2006). However, a recent study indi-
cates that allopregnanolone may modulate anxiety by modula-
tion of the bed nucleus of the stria terminalis (BNST) rather than
the amygdala. In that study, allopregnanolone attenuated
corticotropin-releasing factor (CRF)-enhanced startle but not
fear-potentiated startle (Toufexis et al., 2004). Previous studies
have shown that CRF-enhanced startle is mediated by the BNST,
whereas the amygdala mediates fear-potentiated startle. Conse-
quently, the BNST has been proposed to support longer-lasting
anxiety, and the amygdala has been proposed to support
stimulus-specific fear (Walker et al., 2003). In the present study,
progesterone reduced amygdala responses to specific stimuli (i.e.,
faces). Although our study does not exclude an effect on the
BNST, themodulation of allopregnanolone on the amygdalamay
specifically influence fear (Walker et al., 2003) and/or modulate
more generalized anxiety as suggested by other studies (Akwa et
al., 1999; Walf et al., 2006).
In conclusion, we have used a placebo-controlled progester-
one administration to healthy young women in combination
with event-related fMRI, to provide amechanistic account for the
memory impairing effects of progesterone.Our results reveal that
progesterone impairs memory for faces by reducing neural re-
sponses in the amygdala and fusiform gyrus during encoding and
in the fusiform gyrus and prefrontal cortex during retrieval. The
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Figure 2. Progesterone reduced the recruitment of the fusiform gyrus and inferior frontal gyrus, brain regions that sup-
portedmemory retrieval of faces, during recognitionmemory.A, Significant conjunctionofmaineffect ofmemory (i.e., hits
misses) and main effect of drug [i.e., placebo (faces null events) progesterone (faces null events)] in the right
fusiform gyrus ( y56; p 0.001, uncorrected). B, Parameter estimates of the conjunction cluster (arbitrary units;
mean SEM). C, The progesterone-induced decrease in fusiform gyrus activity predicted the decrease in memory perfor-
mance across subjects [recognition memory accuracy (d)]. D–F, Identical figures for the significant conjunction of main
effects in the left inferior frontal gyrus ( y 26). H, Hits; M, misses; a.u., arbitrary units.
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progesterone-induced decrease in activation predicted the de-
crease inmemory performance across subjects.However, proges-
terone did notmodulate the differential activation between (sub-
sequently) remembered and (subsequently) forgotten faces. This
pattern of results therefore suggests that progesterone impairs
memory by reducing the recruitment of those brain regions that
support memory. These mnemonic effects of progesterone are
likely mediated by its neuroactive metabolite allopregnanolone.
Furthermore, given the important role of the amygdala in the
modulation of memory, these results suggest that allopreg-
nanolone alters memory by influencing amygdala activity, which
in turn may affect memory processes in other brain regions.
These findings reveal a neural mechanism bywhich progesterone
influences emotion and memory, which may contribute to
changes inmood regulation and cognition that are observed dur-
ing the menstrual cycle and pregnancy.
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